• Dear Guest, if you are new here please "sign up" at the top if you'd like to post messages. And if you have used this forum before note we upgraded to new forum software and couldn't transfer the passwords. To get into your account, click on the "log in" button, then click on "Forgot your password?" and reset your password. All previous posts were safely transferred to the new system but custom avatars and private messages unfortunately didn't get moved over. The upside is a newer, simpler, friendly forum.

Who'd have thought it: aspirin against depression

maddog

Regular Member
#1
http://www.ncbi.nlm.nih.gov/pubmed/23506529

BMC Med. 2013 Mar 18;11(1):74. [Epub ahead of print]
Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness.
Berk M, Dean O, Drexhage H, McNeil JJ, Moylan S, Oneil A, Davey CG, Sanna L, Maes M.
Abstract

There is compelling evidence to support an aetiological role for inflammation, oxidative and nitrosative stress (O&NS), and mitochondrial dysfunction in the pathophysiology of major neuropsychiatric disorders, including depression, schizophrenia, bipolar disorder, and Alzheimer's disease (AD). These may represent new pathways for therapy. Aspirin is a non-steroidal anti-inflammatory drug that is an irreversible inhibitor of both cyclooxygenase (COX)-1 and COX-2, It stimulates endogenous production of anti-inflammatory regulatory 'braking signals', including lipoxins, which dampen the inflammatory response and reduce levels of inflammatory biomarkers, including C-reactive protein, tumor necrosis factor- and interleukin (IL)--6 , but not negative immunoregulatory cytokines, such as IL-4 and IL-10. Aspirin can reduce oxidative stress and protect against oxidative damage. Early evidence suggests there are beneficial effects of aspirin in preclinical and clinical studies in mood disorders and schizophrenia, and epidemiological data suggests that high-dose aspirin is associated with a reduced risk of AD. Aspirin, one of the oldest agents in medicine, is a potential new therapy for a range of neuropsychiatric disorders, and may provide proof-of-principle support for the role of inflammation and O&NS in the pathophysiology of this diverse group of disorders.

PMID:
23506529
[PubMed - as supplied by publisher]
 
#2
Well, that now is a very cool news. I had my intuition that aspiring may work best for depression and it worked for me quiet a few times but a research based on it confirms that it is good. Though it is still advisable to consult a physician before trying anything new. ;)
 
Last edited by a moderator:
Top